Stay in the know.
Articles related to Kyle W. Mack, J.D., Pharm.D.
03/03/2023
Mack, Medicinal Psychedelics, Treating Mental Health Conditions
“Medicinal Psychedelics: A Potential Pathway to Treating Mental Health Conditions,” Buffalo Business First, March 2023
08/19/2022
BIPOC Underrepresented in Ketamine Clinical Trials
“Black, Indigenous and People of Color Found to Be Underrepresented in Ketamine Clinical Trials,” Microdose.buzz, August 2022
08/18/2022
Mack, Markov, Improving Diversity In Psychedelics Research
“Strategies For Improving Diversity In Psychedelics Research,” Law360, August 2022
02/18/2022
Kyle W. Mack, Lisa L. Smith, Cannabis Regulations, MRTA
“Cannabis Forethought: Labeling, Warnings and Risk Mitigation,” Buffalo Business First, February 2022
07/22/2021
Mack, Kraus, Regulatory Risk Assessment vs. Tort Law Causation
“Regulatory Risk Assessment vs. Tort Law Causation: A Distinction with a Difference,” Daily Dive, BioPharma Dive Newsletter, July 2021